Clinuvel Pharmaceuticals (CUVL) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 9 66 sessions, July 20, 2026 to October 23, 2026
- Largest daily move
- -11.4% close of August 27, 2026
- 1-month change
- -14.7% closing prices, September 23, 2026 to October 23, 2026
Company Description
Clinuvel Pharmaceuticals (NASDAQ: CUVL) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $251.2M.
CUVL has declined 14.7% over the past month. The last closing price was $4.94.
This page collects what Stock Titan holds for CUVL, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
Clinuvel Pharmaceuticals (CUVL) closed at $4.94 on October 23, 2026. Over the past month, the price has lost 14.7%.
CUVL Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Clinuvel Pharmaceuticals has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. View all CUVL news →
SEC Filings
Clinuvel Pharmaceuticals has filed 8 recent SEC filings, including 8 Form 6-K. The most recent filing was submitted on October 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CUVL SEC filings →
Financial Highlights
Upcoming Events
Headquarters relocation
Workforce reduction
Clinuvel Pharmaceuticals has 2 upcoming scheduled events. The next event, "Headquarters relocation", is scheduled for January 1, 2027 (in 69 days). Investors can track these dates to stay informed about potential catalysts that may affect the CUVL stock price.
Short Interest History
Short interest in Clinuvel Pharmaceuticals (CUVL) currently stands at 12.1 thousand shares, down 54.4% from the previous reporting period, representing 0.0% of the float. Since July 2026, short interest has increased by 9393.7%.
Days to Cover History
Days to cover for Clinuvel Pharmaceuticals (CUVL) currently stands at 1.1 days, up 8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume.
CUVL Company Profile & Sector Positioning
Clinuvel Pharmaceuticals (CUVL) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. Among dividend-paying stocks, CUVL ranks #1,877 by dividend yield.